![]() |
市场调查报告书
商品编码
1822408
肠脑营养市场预测(至 2032 年):按产品类型、形式、应用、最终用户和地区进行的全球分析Gut-Brain Axis Nutrition Market Forecasts to 2032 - Global Analysis By Product, Type, Form, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球肠脑营养市场预计在 2025 年达到 14 亿美元,到 2032 年将达到 35 亿美元,预测期内的复合年增长率为 13.5%。
肠脑营养是指富含纤维的食物和补充剂,例如益生元、益生菌、水果、蔬菜和发酵产品,它们有助于维持肠道健康与大脑功能之间的关联。这些营养丰富的选择不含人工添加剂,能够促进健康的微生物群落、清晰的思维和健康的情绪。这些产品专为注重健康的消费者设计,透过均衡、有益肠道健康的饮食,提供天然的解决方案,增强消化系统和认知健康。
根据《营养学前沿》报道,该市场专注于益生菌和益生元,旨在透过调节肠道微生物群来改善心理健康。
提高心理健康意识
这一市场的发展得益于公众心理健康意识的显着提升以及对肠脑关係理解的不断加深。消费者正在超越传统方法,透过饮食积极管理压力、焦虑和认知功能。科学检验表明,微生物群落如何透过迷走神经和神经传导物质的产生影响情绪和大脑健康,这鼓励人们寻求营养解决方案,而肠脑产品正成为实现整体心理健康的针对性策略。
肠道菌丛的复杂性
一个主要障碍是人体肠道微生物群的高度复杂性和个体差异性。由于每个人的微生物组成都是独一无二的,受饮食、遗传和环境的影响,千篇一律的营养方法往往无法产生一致的效果。这种复杂性使得公司难以做出普遍有效的功效宣传,而当产品未能达到预期效果时,也可能导致消费者产生怀疑。
个人化营养和膳食计划
基于个体微生物组分析制定个人化营养计画蕴含着巨大的商机。肠道微生物组检测(例如粪便样本检测试剂套件)的进步将使企业能够针对特定的益生菌、益生元和旨在纠正个体与心理健康相关的独特微生物失衡的食品提供个人化建议。这种数据主导製化方法能够带来巨大的价值,证明溢价的合理性,提高疗效,并从通用解决方案转向有针对性的干预措施。
误导性行销和虚假宣传
市场面临严重的威胁,例如误导性行销和夸大其词的健康声明,这些声明缺乏坚实的临床证据支持。一些品牌过度宣传其对复杂精神疾病的疗效,这有可能招致消费者失望和监管机构的强烈反对。这种「洗白」行为可能会削弱人们对整个产业的信任,引发美国食品药物管理局 (FDA) 和欧洲食品安全局 (EFSA) 等机构的加强监管,最终导致消费者混淆,并损害合法科学的信誉,从而减缓市场成长。
新冠疫情带来了显着的正面影响,倍增了消费者对整体健康、免疫力以及应对疫情相关压力和焦虑的兴趣。这段时期,心理健康的重要性凸显,人们对预防性自然疗法的兴趣也日益浓厚。居家时间的增加也促进了饮食实验和关于肠脑关係的线上研究,将这些概念引入大众,并使其成为持久的营养趋势。
预计机能性食品市场在预测期内将占据最大份额
机能性食品因其便利性、熟悉度以及易于融入日常饮食的特点,预计在预测期内将占据最大的市场份额。消费者更倾向于从日常食品中获取益处,例如发酵食品(优格、Kefir)、富含纤维的零食和强化食品,而非药丸。由于此类食品降低了进入门槛,支持长期坚持,并有利于既定的饮食习惯,机能性食品很可能占据最大的市场份额,使其成为向广大消费者提供肠脑营养最便捷、最具商业性可扩展性的途径。
预计益生菌部分在预测期内将以最高的复合年增长率成长。
益生菌细分市场预计将在预测期内实现最高成长率,这得益于积极的科学研究和消费者教育,这些研究和教育将特定益生菌菌株与心理健康益处(精神益生菌)直接联繫起来。临床证明,瑞士乳桿菌和长双歧桿菌等菌株可以减轻压力并改善情绪。随着证据的增多,消费者正在积极寻求补充剂和强化双叉桿菌中的这些目标菌株,从而推动创新和优质化。这些目标益处使益生菌成为市场上最具活力和高成长的成分之一。
预计亚太地区将在预测期内占据最大的市场份额,这得益于其深厚的文化历史,即饮食与整体健康息息相关,例如传统中医和阿育吠陀。机能性食品正逐渐获得消费者对身心健康的认可。庞大的人口、不断增长的可支配收入以及泡菜、味噌和康普茶等发酵食品的大量消费量,造就了一个成熟且接受度高的市场,使亚太地区成为肠脑营养产品最大的收益来源。
在预测期内,北美预计将出现最高的复合年增长率,这得益于注重健康的消费者群体、对个人化营养的强劲需求以及健康趋势的快速普及。高数位参与度正在推动肠脑连结的有效教育。该地区是创新中心,许多新兴企业和知名品牌推出了针对性的心理生物补充剂和机能性食品。
According to Stratistics MRC, the Global Gut-Brain Axis Nutrition Market is accounted for $1.4 billion in 2025 and is expected to reach $3.5 billion by 2032 growing at a CAGR of 13.5% during the forecast period. Gut-brain axis nutrition refers to foods and supplements, such as prebiotics, probiotics, or fiber-rich items like fruits, vegetables, and fermented products, that support the connection between gut health and brain function. These nutrient-dense options, free from artificial additives, promote a healthy microbiome, mental clarity, and emotional well-being. Designed for health-conscious consumers, they offer natural solutions to enhance digestion and cognitive health through balanced, gut-friendly diets.
According to Frontiers in Nutrition, this market focuses on probiotics and prebiotics designed to improve mental well-being by modulating the gut microbiome.
Rising awareness of mental health
The market is driven by a significant increase in public awareness of mental health and a growing understanding of the gut-brain connection. Consumers are becoming proactive about managing stress, anxiety, and cognitive function through diet, moving beyond traditional approaches. Scientific validation showing how the microbiome influences mood and brain health via the vagus nerve and neurotransmitter production encourages people to seek nutritional solutions, making gut-brain axis products a targeted strategy for holistic mental wellness.
Complexity of the gut microbiome
A major restraint is the extreme complexity and individuality of the human gut microbiome. A one-size-fits-all nutritional approach often yields inconsistent results because each person's microbial composition is unique, influenced by diet, genetics, and environment. This complexity makes it difficult for companies to make universal efficacy claims, potentially leading to consumer skepticism when products don't deliver expected benefits, thereby hindering widespread trust and adoption without a more personalized approach.
Personalized nutrition and diet plans
A significant opportunity lies in the development of personalized nutrition plans based on individual microbiome analysis. Advances in gut microbiome testing (e.g., stool sample kits) allow companies to offer tailored recommendations for specific probiotics, prebiotics, and foods designed to correct a person's unique microbial imbalances linked to their mental well-being. This data-driven, customized approach adds tremendous value, justifies premium pricing, and increases efficacy, moving beyond generic solutions to targeted interventions.
Misleading marketing and false claims
The market faces a severe threat from misleading marketing and exaggerated health claims that are not fully backed by robust clinical evidence. Some brands may overpromise results for complex mental health conditions, risking consumer disappointment and regulatory backlash. This "gut-washing" can erode trust in the entire category, invite stricter regulations from bodies like the FDA and EFSA, and ultimately slow down market growth by confusing consumers and discrediting legitimate science.
The COVID-19 pandemic had a profoundly positive impact, sharply accelerating consumer focus on holistic health, immunity, and managing pandemic-related stress and anxiety. This period highlighted the importance of mental well-being, driving interest in preventative and natural approaches. Increased time at home led to more dietary experimentation and online research into the gut-brain connection, introducing these concepts to a mass audience and cementing them as a lasting trend in the nutrition landscape.
The functional foods segment is expected to be the largest during the forecast period
The functional foods segment is expected to account for the largest market share during the forecast period, owing to their convenience, familiarity, and ease of integration into daily diets. Consumers prefer obtaining benefits from everyday foods like fermented items (yogurt, kefir), fiber-rich snacks, and fortified products rather than pills. This format lowers the barrier to entry, supports long-term adherence, and leverages established eating habits, making functional foods the most accessible and commercially scalable way to deliver gut-brain axis nutrients to a broad consumer base, thus securing the largest share.
The probiotics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the probiotics segment is predicted to witness the highest growth rate, reinforced by intense scientific research and consumer education directly linking specific probiotic strains to mental health benefits (psychobiotics). Strains like Lactobacillus helveticus and Bifidobacterium longum are clinically shown to reduce stress and improve mood. As evidence grows, consumers actively seek out these targeted strains in supplements and fortified foods, driving innovation and premiumization. This targeted efficacy positions probiotics as the most dynamic and high-growth component within the market.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, ascribed to a deep cultural history of connecting diet with holistic well-being, as seen in Traditional Chinese Medicine and Ayurveda. There is inherent consumer acceptance of functional foods for mental and physical health. A massive population, rising disposable income, and high consumption of fermented foods like kimchi, miso, and kombucha create a mature and receptive market, making APAC the largest revenue generator for gut-brain axis nutrition products.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with a highly health-conscious consumer base, strong demand for personalized nutrition, and a rapid adoption of wellness trends. High digital engagement facilitates effective education on the gut-brain connection. The region is a hub for innovation, with numerous startups and established brands launching targeted psychobiotic supplements and functional foods, supported by significant venture capital funding and a willingness to pay a premium for scientifically-backed mental wellness solutions, driving the fastest growth.
Key players in the market
Some of the key players in Gut-Brain Axis Nutrition Market include Nestle Health Science, Danone S.A., Abbott Laboratories, Procter & Gamble Co., Yakult Honsha Co., Ltd., Chr. Hansen Holding A/S, BASF SE, DuPont de Nemours, Inc., General Mills, Inc., Kerry Group plc, Unilever PLC, PepsiCo, Inc., Coca-Cola Company, Mars, Incorporated, Johnson & Johnson, and AbbVie Inc.
In July 2025, Nestle Health Science launched a new precision probiotic supplement, 'BrainBiome X', specifically formulated with a clinically studied strain of Bifidobacterium longum shown in company trials to support stress management and positive mood by modulating the gut-brain axis.
In May 2025, Danone S.A. introduced its first functional yogurt drink under the Activia brand, 'Activia Mind & Gut', which contains a unique probiotic blend, prebiotic fibers, and vitamins B6 and B12 to nourish the gut-brain connection and support emotional well-being.
In April 2025, Abbott Laboratories received regulatory approval for its new medical nutrition shake, 'Ensure NeuroBiome', designed for older adults. It combines a specific prebiotic fiber with DHA and other nutrients to target cognitive health and gut function through the microbiome.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.